Cargando…

Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer

SIMPLE SUMMARY: This review reports the risk and management of the hepatotoxicity of all the approved protein kinase inhibitors (PKIs) for cancer. Hepatotoxicity is one of the major safety concerns of these drugs, as reflected by the discontinuation of the development of some of them due to liver in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viganò, Mauro, La Milia, Marta, Grassini, Maria Vittoria, Pugliese, Nicola, De Giorgio, Massimo, Fagiuoli, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046041/ https://www.ncbi.nlm.nih.gov/pubmed/36980652 http://dx.doi.org/10.3390/cancers15061766

Ejemplares similares

Reported hepatotoxicity and hepatotoxicity guidance in the product information of protein kinase inhibitors in oncology registered at the European Medicines Agency
por: Maliepaard, Marc, et al.
Publicado: (2023)

Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
por: Hicks, Justin W., et al.
Publicado: (2010)

Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
por: Moccia, Marialuisa, et al.
Publicado: (2015)

Potential of Small Molecule Protein Tyrosine Kinase Inhibitors as Immunomodulators and Inhibitors of the Development of Diabetes
por: Little, Peter J., et al.
Publicado: (2009)

Small Molecule Substrate Phosphorylation Site Inhibitors of Protein Kinases: Approaches and Challenges
por: Breen, Meghan E., et al.
Publicado: (2014)

Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
por: Arter, Chris, et al.
Publicado: (2022)

Decoding kinase-adverse event associations for small molecule kinase inhibitors
por: Gong, Xiajing, et al.
Publicado: (2022)

Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients
por: Viganò, Mauro, et al.
Publicado: (2023)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
por: Gupta, Sachin, et al.
Publicado: (2008)

An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors
por: Moolman, Chantalle, et al.
Publicado: (2020)

Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
por: Moccia, Marialuisa, et al.
Publicado: (2021)

Identification and Characterization of a Small-Molecule Inhibitor of Death-Associated Protein Kinase 1
por: Wilbek, Theis S, et al.
Publicado: (2015)

Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy
por: Lv, Die, et al.
Publicado: (2021)

Checkpoint Inhibitors and Hepatotoxicity
por: Malnick, Stephen D. H., et al.
Publicado: (2021)

Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors
por: Falk, Matthew D., et al.
Publicado: (2014)

Prediction of specificity-determining residues for small-molecule kinase inhibitors
por: Caffrey, Daniel R, et al.
Publicado: (2008)

Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
por: Holderfield, M, et al.
Publicado: (2014)

Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes
por: Luck, Meike, et al.
Publicado: (2021)

A Small Molecule Inhibitor of Bruton’s Tyrosine Kinase Involved in B-Cell Signaling
por: Ratzon, Einav, et al.
Publicado: (2017)

Small Molecules as Protein-Protein Interaction Inhibitors
por: Hajimahdi, Zahra
Publicado: (2016)

Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!
por: Meurer, Steffen K., et al.
Publicado: (2018)

Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase–TPX2 protein–protein interaction
por: Cole, Daniel J., et al.
Publicado: (2017)

Molecular Recognition of FDA-Approved Small Molecule Protein Kinase Drugs in Protein Kinases
por: Zhu, Yan, et al.
Publicado: (2022)

Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin
por: Huertas, D, et al.
Publicado: (2012)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
por: Alsfouk, Aisha
Publicado: (2021)

Identification of a Kinase Profile that Predicts Chromosome Damage Induced by Small Molecule Kinase Inhibitors
por: Olaharski, Andrew J., et al.
Publicado: (2009)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
por: Personeni, Nicola, et al.
Publicado: (2021)

Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!
por: Pollet, Marius, et al.
Publicado: (2018)

Natural Products in Precision Oncology: Plant-Based Small Molecule Inhibitors of Protein Kinases for Cancer Chemoprevention
por: Thompson, Henry J., et al.
Publicado: (2023)

Small-molecule inhibitors of carboxylesterase Notum
por: Zhao, Yuguang, et al.
Publicado: (2021)

Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2
por: Janeček, Matej, et al.
Publicado: (2016)

Light-assisted small molecule screening against protein kinases
por: Inglés-Prieto, Álvaro, et al.
Publicado: (2015)

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
por: Spector, Neil, et al.
Publicado: (2007)

New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors
por: Lin, Nancy U, et al.
Publicado: (2004)

Phenotypic Fingerprinting of Small Molecule Cell Cycle Kinase Inhibitors for Drug Discovery
por: Low, Jonathan, et al.
Publicado: (2009)

Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin
por: Wong, John, et al.
Publicado: (2013)

Selective inhibition of intestinal guanosine 3′,5′-cyclic monophosphate signaling by small-molecule protein kinase inhibitors
por: Bijvelds, Marcel J. C., et al.
Publicado: (2018)

Small molecule branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors with opposing effects on BDK protein levels
por: Roth Flach, Rachel J., et al.
Publicado: (2023)

Small Molecule Inhibitors of Human Papillomavirus Protein - Protein Interactions
por: D’Abramo, C.M, et al.
Publicado: (2011)

Small molecule inhibitors of RAS proteins with oncogenic mutations
por: Orgován, Zoltán, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_32vgna4bca8q8pusk17svq98aj